XOOMAR

Option Care Health (OPCH)

Option Care Health on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as services-home health care services.

Download CSV

8.6M

Short interest

settlement 2026-09-30

3.5

Days to cover

-4.0 days vs prior

34.1%

Short share of volume

2026-10-09

15

Fails to deliver

settlement 2026-09-10

Thu 29 Oct

Next earnings

estimated date

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-10-09.

Short interest

FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSON

As of 30 September 2026, short interest in OPCH is 8,560,769 shares, down 4,106,132 shares over the last month. Over the last 48 readings it ranged from 3,609,104 shares (31 January 2025) to 14,928,361 shares (15 May 2026). At the reported average volume of 2.5M shares a day that is 3.5 days to cover.

Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/opch" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-09-308,560,769-29.2%2,467,3963.47
2026-09-1512,098,760-4.5%1,613,2167.50
2026-08-3112,666,901+5.2%1,746,4157.25
2026-08-1412,041,874-7.5%2,291,0025.26
2026-07-3113,020,353-3.4%2,749,3984.74
2026-07-1513,473,260+1.8%2,062,2426.53
2026-06-3013,239,958+8.1%2,835,4344.67
2026-06-1512,246,358-2.7%2,971,4014.12
2026-05-2912,588,164-15.7%3,266,2013.85
2026-05-1514,928,361+36.4%5,322,0622.80
2026-04-3010,942,843-5.5%3,042,7363.60
2026-04-1511,584,861+9.7%1,797,2916.45
2026-03-3110,561,809+19.0%1,605,0176.58
2026-03-138,874,559+4.5%1,912,6044.64
2026-02-278,496,603+3.6%2,044,7244.16
2026-02-138,199,105-6.1%1,547,2325.30
2026-01-308,734,935+6.0%1,480,8345.90
2026-01-158,236,957-3.7%2,347,2463.51
2025-12-318,551,113-7.6%1,482,2495.77
2025-12-159,258,154+4.8%2,043,2604.53
2025-11-288,835,219+17.1%1,754,6635.04
2025-11-147,547,239-4.7%2,573,2722.93
2025-10-317,916,108+12.3%2,464,6723.21
2025-10-157,047,709+0.9%1,602,0184.40

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 9 October 2026, the short share of OPCH volume is 34.1%, down 22.6 points over the last five sessions. Over the last 30 readings it ranged from 23.8% (6 October 2026) to 71.8% (21 September 2026). The latest reading is 19.8 points below the 30-session average of 53.8%, on 3.7M shares reported.

DateShort volumeTotal volumeShort shareExempt
2026-10-091.3M3.7M34.1%18,149
2026-10-082.2M5.2M43.1%5,222
2026-10-073.3M9.6M34.9%8,817
2026-10-067.1M30.0M23.8%126,452
2026-10-05209K384K54.4%0
2026-10-02252K445K56.7%0
2026-10-01259K409K63.4%49
2026-09-30241K467K51.7%60
2026-09-29318K582K54.6%800
2026-09-28309K681K45.4%3,110
2026-09-25177K380K46.5%1
2026-09-24214K415K51.5%299
2026-09-23295K445K66.3%1
2026-09-22329K597K55.0%0
2026-09-21892K1.2M71.8%13
2026-09-18654K1.0M62.6%0
2026-09-17929K1.6M57.3%1
2026-09-16773K1.4M55.7%1,600
2026-09-15730K1.1M65.4%506
2026-09-14390K593K65.7%3
2026-09-11339K558K60.7%0
2026-09-10293K527K55.6%30
2026-09-09268K403K66.5%29
2026-09-08347K714K48.6%0
2026-09-04307K432K71.1%13
2026-09-03259K443K58.6%120
2026-09-02229K416K55.0%44
2026-09-01202K499K40.4%0
2026-08-31197K401K49.2%3
2026-08-28230K466K49.3%20

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 10 September 2026, the fails-to-deliver balance in OPCH is 15 shares, down 18 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (18 May 2026) to 155,319 shares (7 May 2026). The latest reading sits at the bottom of that range.

SettlementShares failedPriceValue
2026-09-1015$23.64$355
2026-09-0433$24.46$807
2026-09-0142$23.45$985
2026-08-31669$23.90$16K
2026-08-1480$24.07$2K
2026-08-121,087$24.08$26K
2026-08-0344$23.03$1K
2026-07-301,642$23.93$39K
2026-07-28144$21.81$3K
2026-07-20997$21.74$22K
2026-07-1680$22.09$2K
2026-06-2913,901$21.82$303K
2026-06-22626$21.99$14K
2026-06-1844,369$21.71$963K
2026-06-15714$20.76$15K
2026-05-223,360$21.52$72K
2026-05-182$19.52$39
2026-05-12342$19.83$7K
2026-05-11435$20.51$9K
2026-05-083$20.75$62
2026-05-07155,319$20.45$3.2M
2026-05-06141$21.30$3K
2026-05-05180$21.14$4K
2026-05-04377$20.03$8K
2026-04-29100$27.77$3K
2026-04-201,296$28.82$37K
2026-04-1034$29.47$1K
2026-04-094,237$29.16$124K
2026-04-02691$26.49$18K
2026-03-3133,491$27.00$904K

Insider trades

SEC Form 4, newest first, 50 of 100 shown. JSON

No open-market insider trades were reported for OPCH in the last 90 days. The most recent filings are listed below. Latest filing: Bhatia Prateek (EVP Sp Sales & Solutions) on 2026-07-06.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-07-06Bhatia PrateekEVP Sp Sales & SolutionsGrant23K$0.00$040K
2026-07-06Bhatia PrateekEVP Sp Sales & SolutionsGrant16K$0.00$016K
2026-05-20Pate R CarterDirectorGrant9K$0.00$021K
2026-05-20SULLIVAN TIMOTHY PDirectorGrant5K$22.23$108K87K
2026-05-20SULLIVAN TIMOTHY PDirectorGrant9K$0.00$082K
2026-05-20Wright Norman L.DirectorGrant9K$0.00$024K
2026-05-20KRAEMER HARRY M JANSEN JRDirectorGrant12K$22.23$269K471K
2026-05-20KRAEMER HARRY M JANSEN JRDirectorGrant9K$0.00$0459K
2026-05-20Deckmann NatashaDirectorGrant844$22.23$19K32K
2026-05-20Deckmann NatashaDirectorGrant9K$0.00$031K
2026-05-20Bodem Barbara W.DirectorGrant9K$0.00$021K
2026-05-20Bierbower Elizabeth DDirectorGrant9K$0.00$033K
2026-05-20BRANDT ERICDirectorGrant3K$22.23$59K22K
2026-05-20BRANDT ERICDirectorGrant9K$0.00$019K
2026-05-19Smyser CollinGC & Corporate SecretaryTax withholding360$20.86$8K75K
2026-05-19Smyser CollinGC & Corporate SecretaryOption exercise812$0.00$075K
2026-05-07SULLIVAN TIMOTHY PDirectorBuy24K$20.69$500K73K
2026-05-04Sethna MeenalChief Financial OfficerBuy16K$20.16$327K98K
2026-05-04RADEMACHER JOHN CHARLESChief Executive OfficerBuy13K$21.18$265K695K
2026-05-04KRAEMER HARRY M JANSEN JRDirectorBuy37K$21.41$784K450K
2026-04-22Adewunmi FemiChief Medical OfficerTax withholding1K$28.38$40K25K
2026-02-27Pate R CarterDirectorSell30K$32.05$971K12K
2026-02-27Bavaro MichaelChief Human Resources OfficerSell6K$33.00$198K33K
2026-02-24Whitworth LukeChief Operating OfficerTax withholding5K$33.81$156K170K
2026-02-24Smyser CollinGC & Corporate SecretaryTax withholding2K$33.81$75K75K
2026-02-24RADEMACHER JOHN CHARLESChief Executive OfficerTax withholding11K$33.81$374K683K
2026-02-24Maggio NicoleChief Accounting OfficerTax withholding975$33.81$33K28K
2026-02-24Grashoff Christopher L.Chief Growth OfficerTax withholding2K$33.81$67K44K
2026-02-24Bavaro MichaelChief Human Resources OfficerTax withholding1K$33.81$46K39K
2026-02-24Adewunmi FemiChief Medical OfficerTax withholding2K$33.81$55K27K
2026-02-22Whitworth LukeChief Operating OfficerTax withholding24K$35.69$858K174K
2026-02-22RADEMACHER JOHN CHARLESChief Executive OfficerTax withholding133K$35.69$4.7M694K
2026-02-22Smyser CollinGC & Corporate SecretaryTax withholding15K$35.69$551K77K
2026-02-22Maggio NicoleChief Accounting OfficerTax withholding372$35.69$13K29K
2026-02-22Grashoff Christopher L.Chief Growth OfficerTax withholding538$35.69$19K46K
2026-02-22Bavaro MichaelChief Human Resources OfficerTax withholding12K$35.69$436K41K
2026-02-21RADEMACHER JOHN CHARLESChief Executive OfficerTax withholding5K$35.69$177K827K
2026-02-21RADEMACHER JOHN CHARLESChief Executive OfficerOption exercise11K$0.00$0832K
2026-02-20Whitworth LukeChief Operating OfficerTax withholding4K$35.69$143K198K
2026-02-20RADEMACHER JOHN CHARLESChief Executive OfficerTax withholding11K$35.69$380K820K
2026-02-20Smyser CollinGC & Corporate SecretaryTax withholding2K$35.69$72K92K
2026-02-20Maggio NicoleChief Accounting OfficerTax withholding619$35.69$22K30K
2026-02-20Grashoff Christopher L.Chief Growth OfficerTax withholding2K$35.69$70K47K
2026-02-20Bavaro MichaelChief Human Resources OfficerTax withholding1K$35.69$42K53K
2026-02-18Whitworth LukeChief Operating OfficerGrant30K$0.00$0202K
2026-02-18RADEMACHER JOHN CHARLESChief Executive OfficerGrant79K$0.00$0831K
2026-02-18Sethna MeenalChief Financial OfficerGrant27K$0.00$082K
2026-02-18Smyser CollinGC & Corporate SecretaryGrant15K$0.00$094K
2026-02-18Maggio NicoleChief Accounting OfficerGrant4K$0.00$030K
2026-02-18Grashoff Christopher L.Chief Growth OfficerGrant13K$0.00$049K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Planned sales (Form 144)

Newest first. JSON

2 Form 144 notices on file for OPCH worth $1.2M at the prices reported; 0 in the last 90 days worth $0. Latest: Michael L Bavaro filed on 2026-02-27 to sell 6,000 shares ($198K) from 2026-02-27.

FiledSellerSharesMarket valueOf outstandingSale fromBroker
2026-02-27Michael L BavaroOfficer6K$198K0.004%2026-02-27Merrill Lynch
2026-02-26Pate R CarterDirector30K$966K0.019%2026-02-26Fidelity Brokerage Services LLC

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

2 holders report 5% or more of OPCH in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 5.3% of the class (8,228,614 shares), filed 2026-04-30 for an event on 2026-03-31.

FiledFormHolderSharesOf classEvent
2026-08-1413G/Ano. 1Durable Capital Partners LPinvestment adviser, partnership6.2M3.9%2026-06-30
2026-05-0613G/Ano. 1FMR LLCparent holding company6.4M4.1%2026-03-31
2026-05-0613G/Ano. 1Abigail P. Johnsonindividual6.4M4.1%2026-03-31
2026-04-3013GVanguard Capital Managementinvestment adviser8.2M5.3%2026-03-31
2026-04-2913GVanguard Portfolio Managementinvestment adviser8.2M5.2%2026-03-31
2026-03-2713G/Ano. 4The Vanguard Groupinvestment adviser00.0%2026-03-13

13F holders

Tracked managers holding OPCH at their latest 13F. JSON

7 of the 30 tracked managers held OPCH at their latest 13F, $140.8M in total at quarter-end prices. Millennium Management is the largest at $54.9M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 2 cut.

FundQuarterSharesValueOf portfolioChange in shares
Millennium Management2026-06-302.6M$54.9M0.02%+978K
Point72 Asset Management2026-06-301.8M$37.8M0.04%+1.2M
Citadel Advisors2026-06-301.6M$34.3M0.00%-1.9M
D. E. Shaw & Co.2026-06-30284K$6.0M0.00%+134K
AQR Capital Management2026-06-30170K$3.6M0.00%+104K
Bridgewater Associates2026-06-30110K$2.3M0.01%new
Two Sigma Investments2026-06-3098K$2.0M0.00%-86K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In Q1 FY 2026 (quarter ended 2026-03-31) Option Care Health reported revenue of $1.35B, up 1.3% from the same quarter a year earlier, and net income of $45.3M (0.29 diluted EPS). In FY 2025 it generated $258.4M of operating cash flow and spent $310.0M on buybacks. As of 2026-03-31, cash was $177.3M against $1.16B of debt.

Cash
$177.3M
Debt
$1.16B
Equity
$1.35B
Total assets
$3.38B
Shares outstanding
157,027,504

Quarterly, last 8 quarters

QuarterPeriod endRevenueNet incomeMarginDiluted EPS
Q1 FY 20262026-03-31$1.35B$45.3M3.4%0.29
Q4 FY 2025derived2025-12-31$1.47B$58.5M4.0%n/a
Q3 FY 20252025-09-30$1.44B$51.8M3.6%0.32
Q2 FY 20252025-06-30$1.42B$50.5M3.6%0.31
Q1 FY 20252025-03-31$1.33B$46.7M3.5%0.28
Q4 FY 2024derived2024-12-31$1.35B$60.1M4.5%n/a
Q3 FY 20242024-09-30$1.28B$53.9M4.2%0.31
Q2 FY 20242024-06-30$1.23B$53.0M4.3%0.30

Fiscal years, with buybacks and dividends

Fiscal yearEndsRevenueNet incomeOperating cash flowCapexBuybacksDividends
FY 20252025-12-31$5.65B$207.6M$258.4M$41.3M$310.0Mn/a
FY 20242024-12-31$5.00B$211.8M$323.4M$35.6M$252.7Mn/a
FY 20232023-12-31$4.30B$267.1M$371.3M$41.9M$250.3Mn/a
FY 20222022-12-31$3.87B$150.6M$267.5M$35.4M$0n/a
FY 20212021-12-31$3.44B$139.9M$208.6M$25.6M$0n/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-03-31; shares outstanding as of 2026-04-28 from the cover page.

What this page is

Option Care Health in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Option Care Health (OPCH), SEC CIK 1014739, listed on Nasdaq, classified by the SEC as services-home health care services. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest
FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
Daily short volume
FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-10.JSON and CSV
Planned sales
SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-02-27.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
13F holders
SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials
SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-03-31.JSON and CSV
Earnings dates
SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-07-29.JSON and CSV
Insider trades
SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-06.JSON and CSV
Company record
EDGAR filing index for CIK 1014739Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
10 requests a minute without a key, 30 with a free key from a free account.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of OPCH is sold short?
8,560,769 shares were held short at the 2026-09-30 settlement, 3.5 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is OPCH's daily short volume?
On 2026-10-09, 1,270,344 of the 3,731,108 OPCH shares reported to FINRA were sold short, 34.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does OPCH have fails to deliver?
The SEC's latest file shows 15 OPCH shares failed to deliver at settlement 2026-09-10. Fails are reported per settlement date and published twice a month with a lag.
Are OPCH insiders buying or selling?
No open-market insider trades were reported for OPCH in the last 90 days. The most recent filings are listed below. Latest filing: Bhatia Prateek (EVP Sp Sales & Solutions) on 2026-07-06.
Have OPCH insiders filed to sell?
2 Form 144 notices on file for OPCH worth $1.2M at the prices reported; 0 in the last 90 days worth $0. Latest: Michael L Bavaro filed on 2026-02-27 to sell 6,000 shares ($198K) from 2026-02-27.
Who owns 5% or more of OPCH?
2 holders report 5% or more of OPCH in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 5.3% of the class (8,228,614 shares), filed 2026-04-30 for an event on 2026-03-31.
What did OPCH report last quarter?
In Q1 FY 2026 (quarter ended 2026-03-31) Option Care Health reported revenue of $1.35B, up 1.3% from the same quarter a year earlier, and net income of $45.3M (0.29 diluted EPS). In FY 2025 it generated $258.4M of operating cash flow and spent $310.0M on buybacks. As of 2026-03-31, cash was $177.3M against $1.16B of debt.
Which tracked 13F managers own OPCH?
7 of the 30 tracked 13F managers held OPCH shares at their latest filing, $140.8M in all. The largest: Izzy Englander's Millennium Management (2.6M shares, $54.9M), Steve Cohen's Point72 Asset Management (1.8M shares, $37.8M), Ken Griffin's Citadel Advisors (1.6M shares, $34.3M), D. E. Shaw & Co. (284K shares, $6.0M), Cliff Asness's AQR Capital Management (170K shares, $3.6M), Ray Dalio's Bridgewater Associates (110K shares, $2.3M). The table above lists all 7.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.